Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →🤖 ML Fraud Detection Score: 85%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
8,675
Total Claims
$675K
Drug Cost
525
Beneficiaries
$1,285
Cost/Patient
Risk Score Breakdown 21/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+63%
Opioid rate vs peers
4.2% vs 2.6% avg
+20%
Cost per patient vs peers
$1,285 vs $1,068 avg
+43%
Brand preference vs peers
12.9% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
4.2%
Opioid Rate
365
Opioid Claims
$11K
Opioid Cost
14.2%
Long-Acting Rate
Brand vs Generic
Brand: 1,112 claims · $546K
Generic: 7,504 claims · $126K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Insulin Glargine,hum.Rec.Anlog | 34 | $48K |
| Semaglutide | 43 | $47K |
| Apixaban | 64 | $47K |
| Insulin Degludec | 38 | $42K |
| Dulaglutide | 33 | $36K |
| Insulin Detemir | 28 | $31K |
| Insulin Glargine,hum.Rec.Anlog | 66 | $30K |
| Liraglutide | 20 | $23K |
| Rivaroxaban | 36 | $22K |
| Mirabegron | 29 | $20K |
| Sitagliptin Phosphate | 17 | $16K |
| Dapagliflozin Propanediol | 18 | $15K |
| Ticagrelor | 22 | $13K |
| Empagliflozin | 20 | $13K |
| Insulin Aspart | 19 | $12K |
Prescribing Profile
Patient Profile
73
Avg Age
51%
Female
1.26
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About